3M and Ford are collaborating on specific ways the companies can rapidly combine complementary capabilities and resources to help meet a surge in demand for personal protective equipment due to the COVID-19 outbreak.

Hygiene expert Christeyns expands its activities in the Life Science Division with the acquisition of Pliwa, German producer of disinfection products for hospitals and dental care. Although negotiated and signed before the corona crisis, the transaction – which was closed last Friday – will allow Christeyns to increase its production capacity of disinfectants for medical applications. As such the company hopes to provide even better support to the medical sector in these challenging times.

Medivant Health is currently building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona. The first phase will create 10,000 square feet of manufacturing and laboratory space able to produce 40,000 vials of generic drug products every day. Medivant is a new Current Good Manufacturing Practice (CGMP) Manufacturer. Medivant is unique in that its sole purpose is to fill this generic drug shortage void. The facility is fully automated with minimal human intervention.

The answers could help advance the synthesis of new unconventional superconductors and their use for power transmission, transportation and other applications, and also shed light on how the cuprates operate – which is still a mystery after more than 30 years of research.

Climet Instruments Company located in Redlands, California, a Division of Venturedyne Ltd, is the leading manufacturer of pharmaceutical grade cleanroom particle counters and microbial air samplers. Today Climet announced the introduction of their new CI-3100 Trident RS remote particle sensor. This instrument is used in continuous monitoring applications primarily in clean areas within the pharmaceutical, medical device, and biotechnology industries. The CI-3100 Trident RS is also a popular solution among research and development organizations engaged in clinical trials.